Filter
285
Text search:
vaccine
candidates
Featured
Recommendations
33
New Publications
57
Language
Document type
No document type
99
Studies & Reports
62
Guidelines
46
Fact sheets
30
Resource Platforms
12
Strategic & Response Plan
12
Manuals
10
Videos
6
Situation Updates
4
Online Courses
3
Training Material
1
Countries / Regions
Global
16
West and Central Africa
10
India
9
East and Southern Africa
8
Middle East and North Africa
7
Sierra Leone
6
Liberia
6
Africa
6
Russia
6
Nigeria
5
Latin America and the Carribbean
5
Guinea
4
Germany
4
Kenya
4
China
4
South Africa
4
Uganda
3
South Sudan
3
Tanzania
3
Ukraine
3
USA
2
Ethiopia
2
Ghana
2
Haiti
2
Philippines
2
Nepal
2
Syria
2
Brazil
2
Myanmar / Burma
2
Congo, Democratic Republic of
1
Zambia
1
Turkey
1
Thailand
1
Rwanda
1
Indonesia
1
Bangladesh
1
Mozambique
1
North Macedonia
1
Madagascar
1
Western and Central Europe
1
Asia
1
Eastern Europe
1
Timor Leste/ East Timor
1
Kazakhstan
1
Vietnam
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
70
Clinical Guidelines
32
Public Health
10
Key Resources
5
Women & Child Health
4
Pharmacy & Technologies
3
Capacity Building
1
Annual Report MEDBOX
1
Toolboxes
COVID-19
105
TB
24
Rapid Response
17
Ebola
16
HIV
10
NTDs
9
AMR
8
Health Financing Toolbox
8
Zika
6
Polio
4
Global Health Education
4
Cholera
2
Conflict
2
Refugee
2
Caregiver
2
Planetary Health
2
Pharmacy
2
Disability
1
Natural Hazards
1
Mental Health
1
NCDs
1
Long-term polio vaccine security – the timely, sustained, and uninterrupted supply of suitable types of affordable, quality-assured polio vaccines – is essential in the global effort to achieve and maintain a polio free world. However, fragmente
...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence s
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized
...
Vaccines 2021, 9(2), 160; https://doi.org/10.3390/vaccines9020160
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB
...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vac
...
28 Dec 2020. The main objective of these guidelines is to provide tools for staff working in the field of immunization to support effective communication between health personnel and the general population, with the aim of strengthening, maintaining or recovering trust in vaccines and the immunizati
...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pa
...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment
...
Updated 28 December 2020
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID
...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the back
...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19
...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (R
...
updated version: 04/10/2021
Information about vaccine administration
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
